AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys
This study underscores the potential of AT-7687 as a promising addition to current obesity treatments.
Authors
- M. Jensen (ORCID: https://orcid.org/0000-0001-8591-9814)
- METTE MARIE ROSENKILDE (ORCID: https://orcid.org/0000-0001-9600-3254)
- Samra Joke Sanni (ORCID: https://orcid.org/0000-0002-9708-5674)
- Alexander H. Sparre‐Ulrich
- Jens J. Holst (ORCID: https://orcid.org/0000-0001-6853-3805)
- Ditte Riber
Institutions
- University of Copenhagen (DK)
Publication Details
- Journal
- Molecular Metabolism
- Published
- 2024-08-10
- DOI
- https://doi.org/10.1016/j.molmet.2024.102006
- Citations
- 25
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 8.94